Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus
This study does not identify the mechanisms of cardiovascular risk reduction from HCQ. Arterial stiffness is not affected by HCQ. The impact of HCQ on HbA1c and blood lipids is rapid, but of modest magnitude, and these effects do not fully explain the reduced risk of cardiovascular disease seen in observational studies. The mechanisms of cardiovascular risk reduction from HCQ are yet not completely known.
Authors
- Bengt Wahlin (ORCID: https://orcid.org/0000-0002-0893-2326)
- Christine Bengtsson
- Solveig Wållberg‐Jonsson (ORCID: https://orcid.org/0000-0003-1471-3944)
- Anke Braune
- Elias Jönsson
Institutions
- Umeå University (SE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1371/journal.pone.0312546
- Citations
- 7
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 3.29